Literature DB >> 12522070

Anomalous effect of anthracene-9-carboxylic acid on calcium-activated chloride currents in rabbit pulmonary artery smooth muscle cells.

Angela S Piper1, Iain A Greenwood.   

Abstract

1 Ca(2+)-activated Cl(-) currents (I(Cl(Ca))) evoked by K(+)-free pipette solutions containing 500 nM Ca(2+) were recorded in rabbit pulmonary artery smooth muscle cells. A voltage step protocol in which the cells were stepped to +70 mV and then to -80 mV produced outward and inward Cl(-) currents respectively that exhibited distinctive voltage- and time-dependent kinetics that remained consistent for the recording period. 2 Application of the Cl(-) channel inhibitor anthracene-9-carboxylic acid (A-9-C, 500 micro M), produced a small inhibition of the maximum outward Cl(-) current at +70 mV (21+/-10%) but augmented the amplitude of the instantaneous inward relaxation at -80 mV by 321+/-34% (n=12). 3 The current recorded in the absence and presence of A-9-C reversed at the theoretical Cl(-) equilibrium potential and the reversal potential was shifted by about -40 mV upon replacement of external chloride ion by the more permeant anion thiocyanate. Currents in the absence and presence of A-9-C were similarly affected by 100 micro M niflumic acid. 4 Augmentation of the inward current at -80 mV by A-9-C required prior depolarization, i.e. A-9-C did not simply activate a Cl(-) current at negative membrane potentials. Moreover the degree of augmentation was independent of the internal Ca(2+) for concentrations between 100 nM and 1 micro M Ca(2+). 5 The data from the present study confirm previous observations that the inhibitory effect of Cl(-) channel blockers is modified when [Ca(2+)](i) is maintained at higher than normal resting concentrations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12522070      PMCID: PMC1573627          DOI: 10.1038/sj.bjp.0705000

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Tetraethylammonium blockade distinguishes two inactivation mechanisms in voltage-activated K+ channels.

Authors:  K L Choi; R W Aldrich; G Yellen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

2.  Time course of spontaneous calcium-activated chloride currents in smooth muscle cells from the rabbit portal vein.

Authors:  R C Hogg; Q Wang; W A Large
Journal:  J Physiol       Date:  1993-05       Impact factor: 5.182

3.  Activation of potassium currents by inhibitors of calcium-activated chloride conductance in rabbit portal vein smooth muscle cells.

Authors:  C Toma; I A Greenwood; R M Helliwell; W A Large
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

4.  Regenerative component of slow waves in the guinea-pig gastric antrum involves a delayed increase in [Ca(2+)](i) and Cl(-) channels.

Authors:  G D S Hirst; N J Bramich; N Teramoto; H Suzuki; F R Edwards
Journal:  J Physiol       Date:  2002-05-01       Impact factor: 5.182

5.  Ca2+ and Ca(2+)-activated Cl- currents in rabbit oesophageal smooth muscle.

Authors:  H I Akbarali; W R Giles
Journal:  J Physiol       Date:  1993-01       Impact factor: 5.182

6.  Effects of Cl channel blockers on Ca-activated chloride and potassium currents in smooth muscle cells from rabbit portal vein.

Authors:  R C Hogg; Q Wang; W A Large
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

7.  Action of niflumic acid on evoked and spontaneous calcium-activated chloride and potassium currents in smooth muscle cells from rabbit portal vein.

Authors:  R C Hogg; Q Wang; W A Large
Journal:  Br J Pharmacol       Date:  1994-07       Impact factor: 8.739

8.  Comparison of the effects of fenamates on Ca-activated chloride and potassium currents in rabbit portal vein smooth muscle cells.

Authors:  I A Greenwood; W A Large
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

9.  Potentiation of large conductance KCa channels by niflumic, flufenamic, and mefenamic acids.

Authors:  M Ottolia; L Toro
Journal:  Biophys J       Date:  1994-12       Impact factor: 4.033

10.  Cl(-)-channel blockers in the thick ascending limb of the loop of Henle. Structure activity relationship.

Authors:  P Wangemann; M Wittner; A Di Stefano; H C Englert; H J Lang; E Schlatter; R Greger
Journal:  Pflugers Arch       Date:  1986       Impact factor: 3.657

View more
  12 in total

1.  Mechanism of the inhibition of Ca2+-activated Cl- currents by phosphorylation in pulmonary arterial smooth muscle cells.

Authors:  Jeff E Angermann; Amy R Sanguinetti; James L Kenyon; Normand Leblanc; Iain A Greenwood
Journal:  J Gen Physiol       Date:  2006-07       Impact factor: 4.086

2.  Pharmacological properties of native CaCCs and TMEM16A.

Authors:  Kenton M Sanders; Kate O'Driscoll; Normand Leblanc
Journal:  Channels (Austin)       Date:  2014       Impact factor: 2.581

3.  Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways.

Authors:  Kent Miner; Katja Labitzke; Benxian Liu; Paul Wang; Kathryn Henckels; Kevin Gaida; Robin Elliott; Jian Jeffrey Chen; Longbin Liu; Anh Leith; Esther Trueblood; Kelly Hensley; Xing-Zhong Xia; Oliver Homann; Brian Bennett; Mike Fiorino; John Whoriskey; Gang Yu; Sabine Escobar; Min Wong; Teresa L Born; Alison Budelsky; Mike Comeau; Dirk Smith; Jonathan Phillips; James A Johnston; Joseph G McGivern; Kerstin Weikl; David Powers; Karl Kunzelmann; Deanna Mohn; Andreas Hochheimer; John K Sullivan
Journal:  Front Pharmacol       Date:  2019-02-14       Impact factor: 5.810

4.  TMEM16A is implicated in the regulation of coronary flow and is altered in hypertension.

Authors:  Henry R Askew Page; Thomas Dalsgaard; Samuel N Baldwin; Thomas A Jepps; Oleksandr Povstyan; Søren P Olesen; Iain A Greenwood
Journal:  Br J Pharmacol       Date:  2019-04-11       Impact factor: 8.739

5.  Influence of intracellular Ca2+ and alternative splicing on the pharmacological profile of ANO1 channels.

Authors:  Tae Sik Sung; Kate O'Driscoll; Haifeng Zheng; Nicholas J Yapp; Normand Leblanc; Sang Don Koh; Kenton M Sanders
Journal:  Am J Physiol Cell Physiol       Date:  2016-07-13       Impact factor: 4.249

6.  Extracellular protons enable activation of the calcium-dependent chloride channel TMEM16A.

Authors:  Silvia Cruz-Rangel; José J De Jesús-Pérez; Iván A Aréchiga-Figueroa; Aldo A Rodríguez-Menchaca; Patricia Pérez-Cornejo; H Criss Hartzell; Jorge Arreola
Journal:  J Physiol       Date:  2017-01-03       Impact factor: 5.182

7.  Cholesterol depletion alters amplitude and pharmacology of vascular calcium-activated chloride channels.

Authors:  William R Sones; Alison J Davis; Normand Leblanc; Iain A Greenwood
Journal:  Cardiovasc Res       Date:  2010-02-18       Impact factor: 10.787

8.  Inhibition of vascular calcium-gated chloride currents by blockers of KCa1.1, but not by modulators of KCa2.1 or KCa2.3 channels.

Authors:  W R Sones; N Leblanc; I A Greenwood
Journal:  Br J Pharmacol       Date:  2009-07-23       Impact factor: 8.739

9.  Pharmacological characterization of TMEM16A currents.

Authors:  Eamonn Bradley; Stephen Fedigan; Timothy Webb; Mark A Hollywood; Keith D Thornbury; Noel G McHale; Gerard P Sergeant
Journal:  Channels (Austin)       Date:  2014       Impact factor: 2.581

Review 10.  Molecular and functional significance of Ca(2+)-activated Cl(-) channels in pulmonary arterial smooth muscle.

Authors:  Normand Leblanc; Abigail S Forrest; Ramon J Ayon; Michael Wiwchar; Jeff E Angermann; Harry A T Pritchard; Cherie A Singer; Maria L Valencik; Fiona Britton; Iain A Greenwood
Journal:  Pulm Circ       Date:  2015-06       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.